CLB CORE LABORATORIES INC revenue, earnings and financials
For the quarter ended June 30, 2026, CORE LABORATORIES INC reported revenue of $125M (down 4.3% from a year earlier), net income of $5.96M and diluted EPS of $0.13; over the last four quarters revenue was $519M and net income $24.4M; for the fiscal year ended December 2025 revenue was $527M, up 0.5% on the year before.
CLB annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $527M, gross profit n/a, operating income $56.5M, net income $29.7M (margin 5.6%), EPS $0.63
- Fiscal year ended Dec 2024: revenue $524M, gross profit n/a, operating income $58.6M, net income $31.4M (margin 6.0%), EPS $0.66
- Fiscal year ended Dec 2023: revenue $510M, gross profit n/a, operating income $54.6M, net income $36.7M (margin 7.2%), EPS $0.77
- Fiscal year ended Dec 2022: revenue $490M, gross profit n/a, operating income $41.5M, net income $19.5M (margin 4.0%), EPS $0.42
- Fiscal year ended Dec 2021: revenue $470M, gross profit n/a, operating income $45.3M, net income $19.7M (margin 4.2%), EPS $0.42
CLB quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $125M (down 4.3% year over year), net income $5.96M, EPS $0.13
- Quarter ended Mar 31, 2026: revenue $122M (down 1.4% year over year), net income −$789K, EPS −$0.02
- Quarter ended Dec 31, 2025 (from the annual report): revenue $138M (up 7.0% year over year), net income $4.95M, EPS $0.11
- Quarter ended Sep 30, 2025: revenue $135M (up 0.1% year over year), net income $14.2M, EPS $0.30
- Quarter ended Jun 30, 2025: revenue $130M (down 0.3% year over year), net income $10.6M, EPS $0.22
- Quarter ended Mar 31, 2025: revenue $124M (down 4.7% year over year), net income −$154K, EPS $0.00
- Quarter ended Dec 31, 2024 (from the annual report): revenue $129M (up 0.8% year over year), net income $7.40M, EPS $0.15
- Quarter ended Sep 30, 2024: revenue $134M (up 7.2% year over year), net income $11.7M, EPS $0.25
- Quarter ended Jun 30, 2024: revenue $131M (up 2.1% year over year), net income $9.03M, EPS $0.19
- Quarter ended Mar 31, 2024: revenue $130M (up 1.0% year over year), net income $3.22M, EPS $0.07
- Quarter ended Dec 31, 2023 (from the annual report): revenue $128M, net income $2.20M, EPS $0.05
- Quarter ended Sep 30, 2023: revenue $125M (down 0.5% year over year), net income $9.26M, EPS $0.19
- Quarter ended Jun 30, 2023: revenue $128M (up 5.8% year over year), net income $22.8M, EPS $0.48
- Quarter ended Mar 31, 2023: revenue $128M, net income $2.37M, EPS $0.05
- Quarter ended Sep 30, 2022: revenue $126M, net income $7.52M, EPS $0.16
- Quarter ended Jun 30, 2022: revenue $121M, net income $7.07M, EPS $0.15
CLB cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow $37.0M, share buybacks $12.4M
- Fiscal year ended Dec 2024: operating cash flow $56.4M, share buybacks $5.31M
- Fiscal year ended Dec 2023: operating cash flow $24.8M, share buybacks $2.20M
- Fiscal year ended Dec 2022: operating cash flow $25.0M, share buybacks $3.90M
- Fiscal year ended Dec 2021: operating cash flow $36.6M, share buybacks $8.26M
CLB balance sheet
- Jun 30, 2026: cash $22.7M, total assets $587M, total liabilities n/a, shareholders' equity $273M, long-term debt $114M
- Mar 31, 2026: cash $22.8M, total assets $588M, total liabilities n/a, shareholders' equity $269M, long-term debt $114M
- Dec 31, 2025: cash $22.7M, total assets $584M, total liabilities n/a, shareholders' equity $266M, long-term debt $110M
- Sep 30, 2025: cash $25.6M, total assets $591M, total liabilities n/a, shareholders' equity $271M, long-term debt $114M
- Jun 30, 2025: cash $31.2M, total assets $597M, total liabilities n/a, shareholders' equity $261M, long-term debt $125M
- Mar 31, 2025: cash $22.1M, total assets $586M, total liabilities n/a, shareholders' equity $253M, long-term debt $124M
- Dec 31, 2024: cash $19.2M, total assets $585M, total liabilities n/a, shareholders' equity $247M, long-term debt $126M
- Sep 30, 2024: cash $21.5M, total assets $600M, total liabilities n/a, shareholders' equity $251M, long-term debt $140M
What is CLB's revenue?
CORE LABORATORIES INC reported $519M of revenue over its last four quarters, through June 30, 2026.
Is CLB profitable?
Yes. CORE LABORATORIES INC earned $24.4M over the last four quarters.
What is CLB's EPS?
Diluted earnings per share over the last four quarters were $0.52; $0.13 in the latest quarter.